CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 128 enrolled
Drug / intervention
AcQMap Imaging and Mapping Systemdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03368781
NCT03368781N/ACompleted
CompareCT.gov

Utilizing Novel Dipole Density Capabilities to Objectively Visualize the Etiology of Recurrent Atrial Fibrillation Following a Failed AF Ablation (RECOVER AF)

Acutus Medical·interventional·Posted Dec 11, 2017·Updated Jul 27, 2022

In Brief

A clinical study evaluating AcQMap Imaging and Mapping System for Recurrent Atrial Fibrillation. Completed, enrolled 128 participants across 15 sites in 6 countries.

Detailed Summary

A prospective, single-arm, multi-center, multi-national, non-randomized, post-market study designed to provide clinical data regarding the use of the AcQMap High Resolution Imaging and Mapping System during an atrial fibrillation retreatment ablation procedure. (CLP-AF-004 \[EU\]) A prospective, single-arm, multi-center, non-randomized, pre-market study designed to provide clinical data regarding the use of the AcQMap High Resolution Imaging and Mapping System during an atrial fibrillation retreatment ablation procedure. (CLP-AF-005 \[Canada\])

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsRecurrent Atrial Fibrillation
CountriesBelgium, Canada, Czechia, Germany, Netherlands, United Kingdom
Collaborators--

Timeline

N/ACompletedFinished
201820192020202120222023202420252026
First PostedDec 11, 2017
Enrollment StartApr 12, 2018
Primary CompletionOct 29, 2020
TodayJul 2, 2026
Enrollment to primary: 2.5 yearsPosted 8.6 years ago

Interventions

AcQMap Imaging and Mapping Systemdevice

3D Cardiac Imaging and Mapping during ablation procedures